Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF (Leukine) for COVID-19 Pneumonia
NCT04400929Phase 2Completed
- Sponsor
- Singapore General Hospital
- Start
- Jun 2020
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in coronavirus disease 2019 (COVID-19), sponsored by Singapore General Hospital. Started Jun 2020; status: completed.
02
Drugs
sargramostim
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04400929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400929.